Cerner Corporation (CERN)
(Delayed Data from NSDQ)
$68.47 USD
+0.46 (0.68%)
Updated May 3, 2019 04:00 PM ET
After-Market: $68.46 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$68.47 USD
+0.46 (0.68%)
Updated May 3, 2019 04:00 PM ET
After-Market: $68.46 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Bruker (BRKR) Launches the MALDI Biotyper Sirius System
by Zacks Equity Research
The launch is a milestone for Bruker (BRKR) in assay research and clinical studies for fast antibiotic-resistance testing.
IDEXX (IDXX) Gains Traction From Solid CAG, Global Strength
by Zacks Equity Research
IDEXX (IDXX) consistently benefits from strong organic growth, driven by robust sales at the CAG business, fueled by a firm global Catalyst adoption.
Here's Why You Should Add Hologic (HOLX) to Your Portfolio
by Zacks Equity Research
Hologic (HOLX) is generating consistent positive results, courtesy of growth initiatives.
Hologic (HOLX) Inks Deal to Acquire SuperSonic Imagine
by Zacks Equity Research
The acquisition of SuperSonic Imagine is in sync with Hologic's (HOLX) strategy to provide wide-ranging screening, interventional and surgical solutions.
QIAGEN Inks Distribution Deal With Mckesson Medical-Surgical
by Zacks Equity Research
The distribution agreement will enable QIAGEN (QGEN) to expand reach in the healthcare market.
Haemonetics on a High Owing to Firm Plasma Arm, Global Growth
by Zacks Equity Research
Continued traction in new business wins and expansion of geographies are lifting Haemonetics' (HAE) performance of late.
Here's Why You Should Invest in Haemonetics (HAE) Stock Now
by Zacks Equity Research
Haemonetics (HAE) benefits from impressive uptick of Hemostasis Management revenues.
NuVasive Grows on Strong Product Adoption Amid Pricing Woe
by Zacks Equity Research
Introduction of multiple products within the Spinal Hardware, balanced revenue growth across key operating segments and robust international sales perk up NuVasive's (NUVA) share price.
Haemonetics' Plant Sell-Off to CLS Plasma to be Strategic Fit
by Zacks Equity Research
This impending divestment remains integral to Haemonetics' (HAE) asset optimization strategy that aims at improving its operational performance and focusing on core competencies.
Teleflex (TFX) Hits New 52-Week High on Solid Growth Drivers
by Zacks Equity Research
Teleflex (TFX) gains from acquisition of NeoTract and Vascular Solutions.
NuVasive Launches Titanium Spine Implant Modulus TLIF-O
by Zacks Equity Research
The launch of Modulus TLIF-O is expected to boost the AMS portfolio of NuVasive (NUVA).
Align (ALGN), Sraumann Cease Talks on iTero Distribution (Revised)
by Zacks Equity Research
The termination of discussion related to Straumann's iTero distribution is a setback for Align Technologies (ALGN), which is currently focusing on expanding its market base for scanners.
LabCorp Diagnostics Shows Robust Growth Amid Price Declines
by Zacks Equity Research
LabCorp's (LH) Diagnostics business sees an organic uptick in terms of both revenues and volumes in spite of further price reductions.
Align (ALGN) Ceases Straumann Distribution Deal, Shares Slip
by Zacks Equity Research
The termination of the Straumann agreement comes as a setback for Align Technologies (ALGN), which is currently focusing on expanding its market base for scanners.
Abbott (ABT) Hits New 52-Week High on Solid Growth Drivers
by Zacks Equity Research
Abbott (ABT) gains from expansion of product portfolio and several regulatory clearances.
Here's Why You Should Invest in Teleflex (TFX) Stock Now
by Zacks Equity Research
Teleflex (TFX) benefits from rising investors' confidence, courtesy of the NeoTract acquisition.
Computer Programs and Systems to Offer Microsoft HealthVault
by Zacks Equity Research
Computer Programs and Systems' (CPSI ) move indicates its efforts to strengthen foothold in the healthcare information technology (HCIT) space.
Zimmer Biomet Grows Internationally Despite Pricing Pressure
by Zacks Equity Research
Zimmer Biomet (ZBH) witnesses strength in the EMEA and APAC regions as well as in the Spine & CMF business.
Align (ALGN) Introduces Intraoral Scanner, Aids iTero Uptake
by Zacks Equity Research
The latest development in Align Technology's (ALGN) iTero arm is expected to be a perfect strategic fit for the company as it will help it further grow its patient base for intraoral scanner.
Ecolab's (ECL) New Digital Dashboards to Improve Healthcare
by Zacks Equity Research
Ecolab's (ECL) Hand Hygiene Compliance Monitoring System connects with digital dashboards.
Insulet (PODD) Hits 52-Week High on Solid Growth Prospects
by Zacks Equity Research
Insulet (PODD) gains from steady global expansion as well as rollout of innovative products like Omnipod DASH and Omnipod Horizon automated insulin delivery system.
Here's Why You Should Add Cardiovascular Systems (CSII) Stock
by Zacks Equity Research
Cardiovascular Systems (CSII) gains on high investors' confidence, courtesy of consistent positive results.
Boston Scientific's New Products, Acquisitions Boost Growth
by Zacks Equity Research
Boston Scientific (BSX) is pulling out all the stops to strengthen its core businesses as well as invest in new technologies and the overseas markets.
Boston Scientific (BSX) Announces Vertiflex Acquisition
by Zacks Equity Research
The acquisition is in sync with Boston Scientific's (BSX) strategy of expanding pain management portfolio.
Here's Why You Should Hold on to QIAGEN (QGEN) Stock Now
by Zacks Equity Research
QIAGEN (QGEN) is enjoying investors' high confidence, courtesy of the QIAstat-Dx system.